We compared 24,221 type 2 diabetic patients prescribed semaglutide, 49,266 patients prescribed liraglutide, and 45,153 patients prescribed dulaglutide to 551,119 type 2 diabetic patients prescribed insulin to determine whether there were differences in the risk of thyroid cancer in each group
These findings underscore the multifaceted benefits of GLP-1 RAs therapy in patients with type 2 diabetes and AKD
Injectable GHK-Cu Injectable copper peptides work systemically rather than topically
Many users report a natural energy boost, while specific B vitamins may help regulate mood and stress
Weinheimer EM, Sands LP, Campbell WW
There are some early clues